ISSN:

Journal Home

OncoTargets and Therapy Q2 Unclaimed

Dove Medical Press Ltd New Zealand

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

OncoTargets and Therapy is a journal indexed in SJR in Oncology and Pharmacology (medical) with an H index of 94. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 2079 €. The scope of the journal is focused on oncology, cancer, palliative care, therapeutic agents. It has an SJR impact factor of 0,818 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,818.

OncoTargets and Therapy focuses its scope in these topics and keywords: cancer, cell, lung, factor, nonsmallcell, acid, colorectal, growth, induces, nfkappab, ...

Type: Journal

Type of Copyright: CC BY-NC

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Oncology (Q2) Pharmacology (medical) (Q2)

Price

2079 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,818

SJR Impact factor

94

H Index

91

Total Docs (Last Year)

660

Total Docs (3 years)

4592

Total Refs

1836

Total Cites (3 years)

655

Citable Docs (3 years)

2.78

Cites/Doc (2 years)

50.46

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

International Journal of Oncology Q2
Cancer Cytopathology Q2
Cancer Causes & Control Q2
BMC Cancer Q2
Current Opinion in Oncology Q2

Compare this journals